Is Your Phone a Medical Device?
Scholar argues that Congress and FDA should treat risky clinical artificial intelligence tools as medical devices.
Cancer Moonshot Lands with FDA
FDA releases new guidelines for cancer clinical trials in response to President Biden’s anti-cancer initiative.
A Review of Health Care in the Court
Several U.S. Supreme Court cases from this past term have significant implications for the provision of medical care.
The Future of Feces
As fecal microbiota transplantation gains traction in the medical world, regulators may need to step in.
Race and Regulation
Experts examine how regulatory policies disproportionately affect communities of color.
Does Cosmetics Regulation Need a Makeover?
Scholars reflect on the need for stronger regulatory oversight of cosmetics in the United States.
Health Regulation’s Ticking Time Bomb
Under a lingering Trump Administration rule, more than 18,000 regulations could vanish.
Abortion Restrictions After June Medical Services
A concurring opinion leaves the standard for determining the constitutionality of abortion restrictions in doubt.
Tracking Legal Responses to COVID-19
The Regulatory Review’s extensive COVID-19 global series exemplifies Penn Law’s international and cross-disciplinary strengths.
Portugal’s Response to COVID-19
Timely and extensive interventions have facilitated Portugal’s success in addressing COVID-19.
Why Brazil’s COVID-19 Response Is Failing
In Brazil, a political crisis rages between federal and state governments as coronavirus cases keep rising.
Singapore’s Regulatory Response to COVID-19
The pandemic appears tailor-made for Singapore’s managerial and interventionist style of governance.